CDHR4
Cadherin-related family member 4
Also known as: CDH29, CDHR4_HUMAN, VLLR9392
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6H8M9
- Gene
- CDHR4
- Ensembl
- ENSG00000187492
- Chromosome
- 3
- Canonical length
- 788 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
Predicted to enable calcium ion binding activity. Predicted to be involved in cell adhesion. Predicted to be located in membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
788 residues, UniProt reviewed canonical sequence.
>A6H8M9|CDHR4
1 MVLLRLLVFL FAPVVSDLCS LPCFINVSES QGPGTVLQFL SFNCSSYTPT PTLELLNVQP
61 PTTFFNPPSL ARWQGTYVGK LTLSSSAQLD ALMVNHYKVQ LKFTCGNHVM EGSLSVDVQR
121 DLSHIQCAGQ FASPAGEMIQ VPETVTPGAR LYTLLLPGLE LHGAQMSIIS AQDLPHFPGP
181 FSINEQGWLQ APSQGLLGQA QKVFQLQISV SFGQRQSCQG MVIVKVLPVP SSQVSFLEQA
241 QNITIPENLA PGSEVVQVQA RGVDLRYEIL SPVPSPLFSI GRADGVVRTT TPLELARTSG
301 TAVSRLQVKA FEQGQLWASA KLNLTMNVQL VNLWPPRCLP ALLVSQIPET APVGTVLNTL
361 TCEDPDSVGA TLDYKLWFRS SSNPASLCLY DRVLEVNATL DCDTPGACFQ HAASILVLDG
421 GQPQMTTEVP VLVMVTPINE FSPACAPRTF RVQEDAAPHT LLGSVVGTDM DYPHDNIEYY
481 TSGGPTTFAV DRLSGEVHLL GPLDYEQQRL YRLTVLVIDH GQDQNPNHHL SGSCTITIEV
541 EDVNDHAPEC EPPFQELTIY APLGRSVEVT KMSCQIPQEP QRLIYSYSIV GGNSQNRFIL
601 QGAILVHSDL VLGPFWPEQP RTYELLICVA DAGPSTPHLS TTATIIVHLV PRRASTVATS
661 THRTTVPSTM TPMLVTDTEA FWQPQPWFVV VLTATGALLL LALGWLLGRL LQGLAQLLQA
721 PSKPAQALLL NSIQGTEGSI EGFLEAPKME MSQAPSSVMS LHFDGRAQDS RTGRDYLFNT
781 HTGARRWLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDHR4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 56 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 56 nTPM
- lung: 7.4 nTPM
- testis: 7.3 nTPM
- cervix: 3.2 nTPM
- endometrium: 1.6 nTPM
- hypothalamus: 1.6 nTPM
Single-cell type
- respiratory ciliated cells: 253 nCPM
- epididymal efferent duct ciliated cells: 197 nCPM
- fallopian tube ciliated cells: 180 nCPM
- endometrial ciliated cells: 160 nCPM
- ependymal cells: 40 nCPM
- respiratory deuterosomal cells: 12 nCPM
Immune cell
- total PBMC: 3.9 nTPM
- classical monocyte: 2 nTPM
- basophil: 1.7 nTPM
- neutrophil: 1 nTPM
- intermediate monocyte: 0.7 nTPM
- myeloid DC: 0.7 nTPM
Brain region
- midbrain: 13 nTPM
- pons: 7.8 nTPM
- medulla oblongata: 7.5 nTPM
- spinal cord: 3.4 nTPM
- choroid plexus: 3 nTPM
- white matter: 2.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.97
- gnomAD pLI
- 0
- gnomAD missense Z
- 2.18
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDHR4 as an antibody target. Whether an autoantibody or antibody against CDHR4 could matter depends on whether native CDHR4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDHR4 is annotated at the cell surface, where native CDHR4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CDHR4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...